Inventor · disambiguated record
Frank Xinhe Wu
Also filed as: WU FRANK · WU FRANK X H · WU FRANK XINHE
15 granted patents·6 pending applications·180 citations·filing 1990–2019
91Inventor score
Files withSUNOVION PHARMACEUTICALS INC6ENANTA PHARM INC4AGRO KANESHO CO LTD2HEFFERNAN MICHELE L R2HEPTARES THERAPEUTICS LTD2
Top patents by PatentIndex Score
21 records- 0196US7601709B2Macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2004·Granted Oct 13, 2009·60 cites·75 claims
- 0293US7468419B2Cyclosporin derivatives for the treatment of immune disordersENANTA PHARM INC·Filed 2007·Granted Dec 23, 2008·22 cites·8 claims
- 0393US7125845B2Aza-peptide macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2003·Granted Oct 24, 2006·57 cites·17 claims
- 0489US8772301B2Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereofHARDY LARRY WENDELL·Filed 2010·Granted Jul 8, 2014·13 cites·32 claims
- 0589US8124584B2Macrocyclic hepatitis C serine protease inhibitorsMIAO ZHENWEI·Filed 2009·Granted Feb 28, 2012·6 cites·46 claims
- 0680US6187773B1Hexahydrotriazine compounds and insecticidesAGRO KANESHO CO LTD·Filed 1990·Granted Feb 13, 2001·21 cites·4 claims
- 0777US10550089B2Inhibitors of protease-activated receptor-2HEPTARES THERAPEUTICS LTD·Filed 2017·Granted Feb 4, 2020·1 cites·7 claims
- 0868US10640510B2Metabotrophic glutamate receptor 5 modulators and methods use thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted May 5, 2020·0 cites·6 claims
- 0966US10077243B2Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Sep 18, 2018·0 cites·11 claims
- 1065US10995072B2Inhibitors of protease-activated receptor-2HEPTARES THERAPEUTICS LTD·Filed 2019·Granted May 4, 2021·0 cites·13 claims
- 1163US10196399B2Metabotrophic glutamate receptor 5 modulators and methods use thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 5, 2019·0 cites·9 claims
- 1262US2019055204A1Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1361US2007021330A1Aza-peptide macrocyclic hepatitis c serine protease inhibitorsENANTA PHARM INC·Filed 2004·Application pending·0 cites
- 1460US9708331B2Metabotrophic glutamate receptor 5 modulators and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Jul 18, 2017·0 cites·15 claims
- 1556US9260452B2Metabotrophic glutamate receptor 5 modulators and methods of use thereofHEFFERNAN MICHELE L R·Filed 2012·Granted Feb 16, 2016·0 cites·18 claims
- 1655US8497278B2Imidazo[1,2-a]pyridine compoundsFANG QUN KEVIN·Filed 2009·Granted Jul 30, 2013·0 cites·10 claims
- 1751US2013289013A1IMIDAZO[1,2-a]PYRIDINE COMPOUNDSSUNOVION PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1851US2004180815A1Pyridazinonyl macrocyclic hepatitis C serine protease inhibitorsFiled 2003·Application pending·0 cites
- 1950US2004266669A1Cyclosporin derivatives for the treatment of immune disordersFiled 2003·Application pending·0 cites
- 2040US2001046994A1Hexahydrotriazine compounds and insecticidesAGRO KANESHO CO LTD·Filed 2000·Application pending·0 cites
- 2135US10533000B2Metabotrophic glutamate receptor 5 modulators and methods of use thereofHEFFERNAN MICHELE L R·Filed 2012·Granted Jan 14, 2020·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Frank Xinhe Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →